Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease

Lana Mucalo, Amanda M. Brandow, Mahua Dasgupta, Sadie F. Mason, Pippa M. Simpson, Ashima Singh, Bradley W. Taylor, Katherine J. Woods, Fouza I. Yusuf, Julie A. Panepinto

Blood Adv (2021) 5 (13): 2717–2724.

https://doi.org/10.1182/bloodadvances.2021004288

Published: 2021

Includes: Supplemental data

Journal Articles

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma

Donald L. Patrick, Annette Powers, Monika Parisi Jun, Yeonhee Kim, Jacob Garcia, Christine Dehner, David G. Maloney

Blood Adv (2021) 5 (8): 2245–2255.

https://doi.org/10.1182/bloodadvances.2020003503

Published: 2021

Includes: Supplemental data

Journal Articles

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation

Emily Baumrin, Natalie E. Izaguirre, Bruce Bausk, Monica M. Feeley, Camden P. Bay, Qiheng Yang, Vincent T. Ho, Lindsey R. Baden, Nicolas C. Issa

Blood Adv (2021) 5 (6): 1585–1593.

https://doi.org/10.1182/bloodadvances.2020003749

Published: 2021

Includes: Supplemental data

Journal Articles

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain

Amanda M. Brandow, C. Patrick Carroll, Susan Creary, Ronisha Edwards-Elliott, Jeffrey Glassberg, Robert W. Hurley, Abdullah Kutlar, Mohamed Seisa, Jennifer Stinson, John J. Strouse, Fouza Yusuf, William Zempsky, Eddy Lang

Blood Adv (2020) 4 (12): 2656–2701.

https://doi.org/10.1182/bloodadvances.2020001851

Published: 2020

Includes: Supplemental data

Journal Articles

Phase 2 trial of montelukast for prevention of pain in sickle cell disease

Joshua J. Field, Adetola Kassim, Amanda Brandow, Stephen H. Embury, Neil Matsui, Karina Wilkerson, Valencia Bryant, Liyun Zhang, Pippa Simpson, Michael R. DeBaun

Blood Adv (2020) 4 (6): 1159–1165.

https://doi.org/10.1182/bloodadvances.2019001165

Published: 2020

Includes: Supplemental data

Journal Articles

Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield

Blood Adv (2020) 4 (4): 706–716.

https://doi.org/10.1182/bloodadvances.2019000923

Published: 2020

Includes: Supplemental data

Journal Articles

Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis

Kimberly S. Esham, Angie Mae Rodday, Hedy P. Smith, Farzad Noubary, Ruth Ann Weidner, Rachel J. Buchsbaum, Susan K. Parsons

Blood Adv (2019) 4 (1): 19–27.

https://doi.org/10.1182/bloodadvances.2019000128

Published: 2019

Journal Articles

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain

Blood Adv (2019) 3 (23): 3982–4001.

https://doi.org/10.1182/bloodadvances.2019000882

Published: 2019

Includes: Supplemental data

Journal Articles

2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations

M. Hassan Murad, Robert I. Liem, Eddy S. Lang, Elie A. Akl, Joerg J. Meerpohl, Michael R. DeBaun, John F. Tisdale, Amanda M. Brandow, Sophie M. Lanzkron, Stella T. Chou, Starr Webb, Reem A. Mustafa

Blood Adv (2019) 3 (23): 3945–3950.

https://doi.org/10.1182/bloodadvances.2019000931

Published: 2019

Journal Articles

Clinical meaning of PROMIS pain domains for children with sickle cell disease

Ashima Singh, Julie A. Panepinto

Blood Adv (2019) 3 (15): 2244–2249.

https://doi.org/10.1182/bloodadvances.2019000381

Published: 2019

Journal Articles

A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease

Eli L. Diamond, Anne S. Reiner, Justin J. Buthorn, Elyse Shuk, Allison J. Applebaum, David M. Hyman, Omar Abdel-Wahab, Raajit Rampal, Filip Janku, Kathleen Brewer, Jean Campbell, Jun J. Mao, Thomas M. Atkinson, Katherine S. Panageas

Blood Adv (2019) 3 (7): 934–938.

https://doi.org/10.1182/bloodadvances.2018030502

Published: 2019

Journal Articles

Effect of chronic opioid therapy on pain and survival in a humanized mouse model of sickle cell disease

Huy Tran, Varun Sagi, Waogwende Leonce Song-Naba, Ying Wang, Aditya Mittal, Yann Lamarre, Lei Zhang, Kalpna Gupta

Blood Adv (2019) 3 (6): 869–873.

https://doi.org/10.1182/bloodadvances.2018024299

Published: 2019

Includes: Supplemental data

Journal Articles

Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial

Ersi Voskaridou, Ioannis Ntanasis-Stathopoulos, Athanasios Papaefstathiou, Dimitrios Christoulas, Maria Dimopoulou, Konstantina Repa, Athanasios Papatheodorou, Melpomeni Peppa, Evangelos Terpos

Blood Adv (2018) 2 (21): 2837–2847.

https://doi.org/10.1182/bloodadvances.2018023085

Published: 2018

Includes: Supplemental data

Journal Articles

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

Ahmed A. Daak, Carlton D. Dampier, Beng Fuh, Julie Kanter, Ofelia A. Alvarez, L. Vandy Black, Melissa A. McNaull, Michael U. Callaghan, Alex George, Lynne Neumayr, Lee M. Hilliard, Fredrick Sancilio, Adrian L. Rabinowicz, Matthew M. Heeney

Blood Adv (2018) 2 (15): 1969–1979.

https://doi.org/10.1182/bloodadvances.2018021444

Published: 2018

Includes: Supplemental data

Journal Articles

The use of defibrotide in blood and marrow transplantation

Paul G. Richardson, Enric Carreras, Massimo Iacobelli, Bijan Nejadnik

Blood Adv (2018) 2 (12): 1495–1509.

https://doi.org/10.1182/bloodadvances.2017008375

Published: 2018

Journal Articles

Identification of patients with hemoglobin SS/Sβ 0 thalassemia disease and pain crises within electronic health records

Ashima Singh, Javier Mora, Julie A. Panepinto

Blood Adv (2018) 2 (11): 1172–1179.

https://doi.org/10.1182/bloodadvances.2018017541

Published: 2018

Includes: Supplemental data

Journal Articles

Depression, quality of life, and medical resource utilization in sickle cell disease

Soheir S. Adam, Charlene M. Flahiff, Shital Kamble, Marilyn J. Telen, Shelby D. Reed, Laura M. De Castro

Blood Adv (2017) 1 (23): 1983–1992.

https://doi.org/10.1182/bloodadvances.2017006940

Published: 2017

Includes: Supplemental data

Journal Articles

Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review

Joep W. R. Sins, David J. Mager, Shyrin C. A. T. Davis, Bart J. Biemond, Karin Fijnvandraat

Blood Adv (2017) 1 (19): 1598–1616.

https://doi.org/10.1182/bloodadvances.2017007211

Published: 2017

Includes: Supplemental data

Journal Articles

Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California

Oyebimpe Adesina, Ann Brunson, Theresa H. M. Keegan, Ted Wun

Blood Adv (2017) 1 (16): 1287–1295.

https://doi.org/10.1182/bloodadvances.2017005256

Published: 2017

Includes: Supplemental data

Journal Articles

Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge

Michaela Kuhlen, Marina Kunstreich, Kathinka Krull, Roland Meisel, Arndt Borkhardt

Blood Adv (2017) 1 (14): 981–994.

https://doi.org/10.1182/bloodadvances.2017007286

Published: 2017

NARROW

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain

Phase 2 trial of montelukast for prevention of pain in sickle cell disease

Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield

Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain

2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations

Clinical meaning of PROMIS pain domains for children with sickle cell disease

A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease

Effect of chronic opioid therapy on pain and survival in a humanized mouse model of sickle cell disease

Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

The use of defibrotide in blood and marrow transplantation

Identification of patients with hemoglobin SS/Sβ 0 thalassemia disease and pain crises within electronic health records

Depression, quality of life, and medical resource utilization in sickle cell disease

Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review

Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California

Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only